Women With ADD Are More Impaired

<!-- @page { size: 21cm 29.7cm; margin: 2cm } P { margin-bottom: 0.21cm } -->

On April 24, 2008, the US Food and Drug Administration approved Lisdexamfetamine - known as Vyvanse - to be used for adult ADD and ADHD. Prior to this announcement, the medicine was just approved for use in children aged 6-12.